
FDA Panel Challenges Hormone Replacement Therapy Risks
An FDA panel of menopause experts met today to review the current FDA warning labels on hormone therapy for menopausal women. Experts discussed the issues with the labels and the need for education and hormone access. The meeting was organized by FDA …